IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Mineralys Therapeutics Inc

CUSIP: SBP9N0G08 | 1 institutional holders

Quarters

Q1 2023
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q1 2023

Metropolitan Life Insurance Co727
0.0% of portfolio›$11.4K
StyleTurnoverLocationFiled
Metropolitan Life Insurance Co
727$11.4K0.0%ETFVery LowNew York, NY2023-05-15